Westinghouse General Counsel Issues Statement on CB&I Legal Proceeding
In October, 2015, Westinghouse entered into a Purchase Agreement with Chicago Bridge & Iron Company N.V. (CB&I) for the acquisition of CB&I Stone & Webster Inc., CB&I’s nuclear construction and integrated services businesses by Westinghouse. On July 21, 2016, CB&I initiated a legal proceeding against Westinghouse in Delaware Chancery Court with respect to the post-closing reconciliation process.
Today Westinghouse Senior Vice President and General Counsel Michael Sweeney issued the following statement in response to the legal proceeding brought by CB&I.
"Over the course of the past several months the two parties have been faithfully following the process explicitly set out in the Purchase Agreement between them. It is therefore troubling that CB&I, after agreeing to and actively participating in that process, is seeking to disrupt it. Nevertheless, we are confident that the transaction will be fully concluded in accordance with the Parties Purchase Agreement.”
To learn more about Westinghouse Electric Company and our vision to be the first to innovate the next technology, practice or solution that helps our customers generate safer, cleaner, more reliable energy visit www.westinghousenuclear.com .
Westinghouse Electric Company
Courtney Boone, +1 412-374-2707
Director, Press Relations and Public Affairs
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
PA-WESTINGHOUSE-ELECTRIC21.6.2018 22:26 | pressemeddelelse
First Westinghouse AP1000® Nuclear Plant Sanmen 1 Completes Initial Criticality
PA-WESTINGHOUSE-ELECTRIC21.6.2018 22:09 | pressemeddelelse
Westinghouse Loads Fuel in Second AP1000® Nuclear Power Plant
PHARNEXT21.6.2018 20:25 | pressemeddelelse
Pharnext to Announce Top-Line Results from the Pivotal Phase 3 Trial of PXT3003 for the Treatment of Charcot-Marie-Tooth Type 1A Disease by October 2018
PHILIP-MORRIS-INTERNATIO21.6.2018 20:15 | pressemeddelelse
Philip Morris International Makes Call to Creative, Media and Communications Communities
IBC21.6.2018 18:32 | pressemeddelelse
IBC2018 Announces Cyber Security Forum to Help Media Tackle Cyber Threats
MENSIA-TECHNOLOGIES21.6.2018 18:25 | pressemeddelelse
Mensia Technologies Raises 1,3 Million Euro to Introduce Koala Neurofeedback as a Revolutionary Medical Device in Europe
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum